HLA‐DR<sup>neg</sup> patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia
Uta Oelschlaegel(University Hospital Carl Gustav Carus), Christian Thiede(University Hospital Carl Gustav Carus), Markus Schaich(Rems-Murr-Klinikum), Ulrike Schäkel(Health First), Thomas Illmer(Center for Systems Biology Dresden), Frank Kroschinsky(University Hospital Carl Gustav Carus), Brigitte Mohr(Klinik und Poliklinik für Psychotherapie und Psychosomatik), Gerhard Ehninger(University Hospital Carl Gustav Carus)
Cited by 42
Related Papers
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2018|1k